NASDAQ
Federated Hermes Inc. reduced its position in Omnicell, Inc. (NASDAQ: OMCL) by 20.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commissi...
Omnicell, Inc. (OMCL) Discusses Launch of Titan XT Enterprise Platform and Its Impact on Pharmacy Operations Transcript...
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value...
FORT WORTH, Texas--(BUSINESS WIRE)--Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management....
OMCL's expanding SaaS pipeline, global push and solid solvency highlight growth potential despite rising competition....
Capital Fund Management S.A. grew its stake in shares of Omnicell, Inc. (NASDAQ: OMCL) by 97.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show....
The consensus price target hints at a 30.9% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference....
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option fo...
No price data available for this timeframe.